(Q42456722)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Pieter F van der Meer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Dirk de Korte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Laura Gutiérrez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

2

Iris M De Cuyper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Sabrina Zeddies

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Brunette B Daal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Daphne C Thijssen-Timmer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

1 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

2292-2300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24689812%20AND%20SRC:MED&resulttype=core&format=json

Improving the bacteriological safety of platelet transfusions

12 March 2020

cites work

1 reference

10 Years Experience with Bacterial Screening of Platelet Concentrates in the Netherlands

21 January 2018

1 reference

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

21 January 2018

1 reference

Transfusion-transmitted malaria: current donor selection guidelines are not sufficient

21 January 2018

1 reference

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

21 January 2018

1 reference

Binding affinities of commonly employed sensitizers of viral inactivation

21 January 2018

1 reference

Comparison of the DNA-damaging property of photosensitised riboflavin via singlet oxygen (1O2) and superoxide radical O2-. mechanisms.

21 January 2018

1 reference

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

21 January 2018

1 reference

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

21 January 2018

1 reference

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

21 January 2018

1 reference

Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates

21 January 2018

1 reference

Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study

21 January 2018

1 reference

The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.

21 January 2018

1 reference

Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment

21 January 2018

1 reference

Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway

21 January 2018

1 reference

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

21 January 2018

1 reference

A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation

21 January 2018

1 reference

Blood platelet biochemistry

21 January 2018

1 reference

Platelet receptor signaling in thrombus formation

21 January 2018

1 reference

A novel flow cytometry-based platelet aggregation assay.

21 January 2018

1 reference

Fiji: an open-source platform for biological-image analysis

21 January 2018

1 reference

Platelet-collagen interaction: is GPVI the central receptor?

21 January 2018

1 reference

Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.

21 January 2018

1 reference

Platelets at work in primary hemostasis.

21 January 2018

1 reference

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

21 January 2018

1 reference

Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants

21 January 2018

1 reference

White blood cell inactivation after treatment with riboflavin and ultraviolet light

21 January 2018

1 reference